Give answers for theory exam in PSM for third MBBS level. The answer should be pinned to point and grips important points, no extra information. Give answer based on all available standard resources and remember that the answer should be an examiner pleaser, not so examiner can see the important points easily and highlight important points and all, make a structure so it will be easy for examiner to scan the answers easily and also important point and answer should be writable in a 10 to 12 minutes assuming the speed of writing is moderate. The first topic is human development index. Use mind maps diagram and flow charts where ever. Necessary

Reading File
Finding Sources
Searching the Web

human development index PSM community medicine third MBBS exam answer components HDI UNDP

Reading File
Reading File
Loading Image
Now I have all the data from Park's Textbook. Let me compose the answer.

Human Development Index (HDI)

[PSM - 3rd MBBS Theory Answer | ~10-12 min write time]

1. DEFINITION ⭐

HDI is a composite index measuring achievement in three basic dimensions of human development: Long healthy life + Knowledge + Decent standard of living
  • Introduced by UNDP (United Nations Development Programme)
  • Values range from 0 to 1 (higher = better development)

2. DIMENSIONS & INDICATORS (FLOWCHART from Park's)

HDI Construction Diagram from Park's Textbook
DIMENSION          INDICATOR(S)
─────────────────────────────────────────────────────
Long & Healthy     Life Expectancy at Birth
Life               ↓
                   Life Expectancy Index
─────────────────────────────────────────────────────
Knowledge          Mean Years of Schooling (adults ≥25 yrs)
                   + Expected Years of Schooling (school-entering age)
                   ↓
                   Education Index
─────────────────────────────────────────────────────
Decent Standard    GNI per capita (PPP US $)
of Living          ↓
                   GNI Index
─────────────────────────────────────────────────────
                   ↓↓↓
              [GEOMETRIC MEAN of all 3]
                   ↓
              HUMAN DEVELOPMENT INDEX

3. STEPS TO CALCULATE HDI

Step 1 - Create Dimension Index (Sub-index)

Formula:
Dimension Index = (Actual value - Minimum value)
                  ─────────────────────────────────
                  (Maximum value - Minimum value)

Step 2 - Calculate HDI

HDI = Geometric Mean of 3 Dimension Indices
    = (Life Expectancy Index × Education Index × GNI Index)^(1/3)
Note: For Education, geometric mean of the two sub-indices is taken first, then equation re-applied.

4. GOALPOSTS (Min & Max Values) - TABLE ⭐

DimensionIndicatorMaximumMinimum
HealthLife expectancy (yrs)83.220
EducationMean yrs of schooling13.20
EducationExpected yrs of schooling20.60
EducationCombined Education Index0.9510
Standard of LivingGNI per capita (PPP $)1,08,211163

5. HDI CLASSIFICATION - MIND MAP

              HDI VALUE
                 │
    ┌────────────┼────────────┬────────────┐
    │            │            │            │
  <0.550     0.550-0.699   0.700-0.799   ≥0.800
    │            │            │            │
   LOW         MEDIUM        HIGH       VERY HIGH
  HDI          HDI           HDI         HDI

6. KEY FACTS FOR EXAM ⭐⭐

PointFact
Introduced byUNDP
Year first published1990
Range0 to 1
Calculation methodGeometric mean (NOT arithmetic)
Income measure usedGNI per capita in PPP US$
India's rank (2018)129th - Medium HDI category
Top countries (2018)Norway, Ireland, Switzerland
Bottom countries (2018)Niger, Central African Republic

7. IMPORTANCE / SIGNIFICANCE

  • More comprehensive than per capita income alone
  • Income is a means, not an end - HDI goes beyond income
  • Focuses on human outcomes rather than economic statistics
  • Two countries with same income can have very different HDI (e.g., different life expectancy/literacy)
  • Used by policy makers, media, NGOs to direct interventions
  • Highlights regional disparities in human development

8. LIMITATIONS (Bonus if time permits)

  • Does not capture inequality within countries
  • Does not reflect gender disparities (separate Gender Development Index exists)
  • Does not include environmental sustainability
  • Only 4 indicators - oversimplified

Source: Park's Textbook of Preventive and Social Medicine (reference standard for MBBS PSM)

Examiner Tip: The most likely exam focus points are: definition, 3 dimensions + their indicators, the classification table (Low/Medium/High/Very High), and the formula using geometric mean. These 4 components alone cover 80% of marks typically allocated to this topic.

Iceberg phenomenon of disease

Finding Sources
Reading File
Finding Sources
Finding Sources
Loading Image
Reading File
I now have everything needed. Here is the complete exam answer:

Iceberg Phenomenon of Disease

[PSM - 3rd MBBS Theory Answer | ~10-12 min write time]

1. CONCEPT / DEFINITION ⭐

Disease in a community can be compared to an iceberg - only the tip is visible above the waterline, while the vast mass remains hidden below.
  • The pattern of disease in hospitals is very different from the pattern in the community
  • A far larger proportion of disease is hidden from view than is evident to physicians or the general public
  • Closely related to the Spectrum of Disease

2. THE ICEBERG DIAGRAM (Park's Fig. 10) ⭐⭐

(Draw this in exam - easy marks)
Iceberg of Disease - Park's Textbook
 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
        ▲  FLOATING TIP (VISIBLE)
        |  → Symptomatic / Clinical disease
        |  → What the PHYSICIAN SEES
 ═══════╪══════════════ WATERLINE ═════════════
        |  → Apparent ←→ Inapparent demarcation
        |
        ▼  SUBMERGED PORTION (HIDDEN MASS)
           → Subclinical cases
           → Carriers
           → Latent cases
           → Presymptomatic cases
           → Undiagnosed cases
           → What the PHYSICIAN DOES NOT SEE
 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

3. COMPONENTS OF THE ICEBERG - MIND MAP

                    ICEBERG OF DISEASE
                          │
          ┌───────────────┴────────────────┐
     ABOVE WATERLINE                BELOW WATERLINE
    (Apparent Disease)            (Inapparent Disease)
          │                              │
    ┌─────┤                   ┌──────────┼──────────────┐
  Clinical │              Subclinical  Latent       Carriers
  cases    │              infections   cases            │
    │      │                   │          │       (e.g., Typhoid,
  Mild   Severe           No symptoms  Dormant      Hepatitis B)
  cases  cases               yet       infection         │
                                                  Presymptomatic
                                                     cases

4. EXAMPLES BY DISEASE ⭐⭐

DiseaseClinical (Tip)Subclinical (Hidden)Ratio
PoliomyelitisParalytic casesInapparent infections1 : 1000 (children)
HypertensionKnown casesUndiagnosed casesLarge hidden portion
DiabetesDiagnosedUndiagnosedHuge hidden mass
TBActive casesLatent TB infection~1.7 billion latent globally
AnaemiaKnownUndetectedLarge hidden portion
Mental illnessTreatedUntreated/undiagnosedVast hidden mass
MalnutritionSevere/obviousMild/moderateHidden portion larger

5. SIGNIFICANCE / IMPORTANCE ⭐

  1. Reservoir of infection - hidden cases act as undetected source of spread
  2. True burden underestimated - hospital/clinic data does not reflect community disease load
  3. Basis for Screening - justifies active search for disease in apparently healthy individuals
  4. Public health challenge - detection and control of hidden portion is the goal of preventive medicine
  5. Epidemiological tool - explains why incidence > reported cases

6. WATERLINE = KEY CONCEPT

ABOVE WATERLINE              BELOW WATERLINE
─────────────────────        ─────────────────────────────
Apparent disease             Inapparent disease
Diagnosed cases              Undiagnosed / subclinical
Physician sees               Physician does NOT see
Morbidity statistics capture These are MISSED in data

7. RELATIONSHIP WITH SPECTRUM OF DISEASE

SPECTRUM OF DISEASE (Continuous)
├── Subclinical/Inapparent ──── [BELOW waterline = Iceberg base]
├── Mild illness
├── Moderate illness            [ABOVE waterline = Iceberg tip]
├── Severe illness
└── Death
The Iceberg concept gives a better picture of sub-clinical to overt disease progression than the spectrum of disease alone.

8. SOLUTION TO THE ICEBERG PROBLEM ⭐

DETECTION OF HIDDEN DISEASE
        │
        ├── SCREENING PROGRAMMES
        │       (mass/selective/multiphasic)
        │
        ├── ACTIVE SURVEILLANCE
        │
        ├── COMMUNITY SURVEYS
        │
        └── HEALTH CAMPS / OUTREACH
Screening = "search for unrecognized disease by rapidly applied tests in apparently healthy individuals" - this directly addresses the submerged portion of the iceberg.

Source: Park's Textbook of Preventive and Social Medicine

Epidemiological triad

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Loading Image
Now I have all the data. Here is the complete structured exam answer:

Epidemiological Triad

[PSM - 3rd MBBS Theory Answer | ~10-12 min write time]

1. INTRODUCTION / BACKGROUND ⭐

  • The Germ Theory of disease (single cause) was found insufficient
  • Example: Not everyone exposed to TB bacilli develops TB - host and environment also matter
  • This demanded a broader concept synthesizing Agent + Host + Environment
  • The Epidemiological Triad is based on the communicable disease model

2. THE TRIAD DIAGRAM ⭐⭐ (Draw in exam)

Epidemiological Triad - Park's Fig. 4
              ENVIRONMENT
                  /\
                 /  \
                /    \
               /      \
              /________\
           AGENT        HOST
Disease occurs when the BALANCE between the three is disturbed Prevention = Break one leg of the triangle

3. COMPONENT 1 - AGENT ⭐⭐

The cause of disease

Classification of Agents:

                        AGENT
                          │
        ┌─────────────────┼──────────────────┐
   BIOLOGICAL          PHYSICAL            CHEMICAL
        │                  │                  │
  Bacteria             Radiation          Poisons/toxins
  Viruses              Heat/cold          Drugs
  Fungi                Trauma             Allergens
  Parasites            Noise              Nutritional
  Rickettsia                              deficiency/excess
  Helminths

Properties of Agent (Biological) - KEY POINTS:

PropertyDefinition
InfectivityAbility to enter and establish in host
PathogenicityAbility to produce disease in infected host
VirulenceSeverity of disease produced
AntigenicityAbility to produce immune response
InvasivenessAbility to invade tissues
ToxigenicityAbility to produce toxins

4. COMPONENT 2 - HOST ⭐⭐

An organism (usually human/animal) that harbours the disease

Host Factors (Mind Map):

                      HOST FACTORS
                           │
      ┌──────────┬──────────┼──────────┬────────────┐
   INTRINSIC   GENETIC    IMMUNO-    BEHAV-      NUTRI-
   FACTORS     MAKEUP     LOGICAL    IOURAL      TIONAL
      │           │       STATUS     FACTORS     STATUS
   Age           Race        │           │          │
   Sex        Sickle cell  Immunity  Lifestyle   Under/over
   Ethnicity  trait        Natural   Habits      nutrition
              HLA type     Acquired  Occupation
Key determinants: Age, Sex, Genetic constitution, Immunity, Nutrition, Behaviour, Occupation

5. COMPONENT 3 - ENVIRONMENT ⭐⭐

All external conditions and surroundings of the host that affect disease transmission

Three Types:

TypeExamples
BiologicalVectors (mosquitoes, flies), reservoir hosts, food contamination
PhysicalClimate, season, geography, temperature, radiation
Social/PsychosocialPoverty, overcrowding, sanitation, education, culture, lifestyle

6. ROLE OF TIME ⭐

  • Added to create the "Triangle of Epidemiology" (Fig. 5, Park's)
  • Accounts for:
    • Incubation period
    • Life expectancy of host/pathogen
    • Duration of illness
    • Epidemic threshold timing

7. DISEASE STATES - INTERACTION DIAGRAM

EQUILIBRIUM (No disease)
Agent ←──── balanced ────→ Host
              ↕
          Environment

DISEASE OCCURS when:
┌──────────────────────────────────────────┐
│ Agent virulence ↑                        │
│ OR Host resistance ↓                     │
│ OR Environment favours agent over host   │
└──────────────────────────────────────────┘

8. EXAMPLES OF TRIAD IMBALANCE

DiseaseAgentHost factorEnvironment
TBM. tuberculosisMalnutrition, immunosuppressionOvercrowding, poverty
MalariaPlasmodiumNo immunity, ageStagnant water, vector habitat
Rheumatic feverStrep pyogenesGenetic susceptibilityOvercrowding, cold
CHDMultipleGenetics, age, sexSedentary lifestyle, diet

9. LIMITATIONS OF THE TRIAD ⭐

  1. Suitable mainly for infectious diseases - less applicable to chronic/non-communicable diseases
  2. Does not show interaction and interdependence between factors (Web of Causation better for this)
  3. Does not account for multiple causation well
  4. Replaced/supplemented by: Web of Causation (MacMahon & Pugh) for chronic diseases

10. SIGNIFICANCE / USE

USES OF EPIDEMIOLOGICAL TRIAD
         │
    ┌────┴────┐
    │         │
Understanding  Designing
disease        INTERVENTIONS
causation      │
               ├── Target AGENT (antibiotics, vaccines)
               ├── Target HOST (immunization, nutrition)
               └── Target ENVIRONMENT (sanitation, vector control)
Key principle: Break ANY ONE leg of the triangle = disease prevented/controlled

Source: Park's Textbook of Preventive and Social Medicine (Fig. 4 & 5)

Now these are concepts in PSM give all imp points in them revivable in half hour presentable manner

Concept one epidemiology

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I have all the data needed. Here is the complete 30-minute revision sheet:

⚡ EPIDEMIOLOGY - 30-MIN RAPID REVISION SHEET

[PSM | 3rd MBBS | All key points for exam]

🔑 1. DEFINITION (Most important - learn verbatim)

"The study of the occurrence and distribution of health-related events, states, and processes in specified populations, including the study of the determinants influencing such processes, and the application of this knowledge to control relevant health problems."IEA Definition (International Epidemiological Association)
Simpler older definition: "The study of distribution and determinants of disease frequency in man" — MacMahon & Pugh

🔑 2. THREE CORE COMPONENTS

        EPIDEMIOLOGY
             │
    ┌────────┼────────┐
    │        │        │
FREQUENCY DISTRIBUTION DETERMINANTS
    │        │        │
  Rates &  Person    Causes/
  Ratios   Place     Risk factors
           Time
ComponentWhat it does
Disease FrequencyRates, ratios - prevalence, incidence, death rates
DistributionPerson, Place, Time (3 P's)
DeterminantsBiological, social, behavioural, economic, political factors

🔑 3. AIMS (IEA - 3 Aims)

  1. Describe distribution and magnitude of health & disease in populations
  2. Identify aetiological factors (risk factors) in pathogenesis
  3. Provide data for planning, implementation, evaluation of health services
Ultimate aim: Eliminate/reduce health problems + Promote well-being of society

🔑 4. SCOPE OF EPIDEMIOLOGY

SCOPE OF EPIDEMIOLOGY
        │
   ┌────┴────┬──────────┬──────────┐
   │         │          │          │
Infectious  Chronic  Accidents  Mental
Diseases    Diseases             Health
   │         │
Endemic   Non-communicable
Epidemic  diseases (CHD, Ca)
   │
Health services &
Health-related states

🔑 5. USES OF EPIDEMIOLOGY (Morris - 7 Uses) ⭐⭐

#UseKey Point
1History of diseaseRise & fall - emerging/disappearing diseases
2Community diagnosisIdentify + quantify health problems; epidemiology = "diagnostic tool of community medicine"
3Planning & EvaluationRational resource allocation; evaluate services by RCTs
4Individual risk assessmentRelative risk, attributable risk (e.g., smoker vs non-smoker)
5Syndrome identificationDefine/refine syndromes by group observation
6Natural history of diseaseComplete the disease picture beyond hospital data
7Searching for causes/risk factorsIdentify aetiology → prevention strategies
Mnemonic: History Community Planning Risk Syndrome Natural Causes = HCP RS NC

🔑 6. TYPES OF EPIDEMIOLOGY

EPIDEMIOLOGY
      │
 ┌────┴────────────┐
 │                 │
DESCRIPTIVE    ANALYTICAL
 │                 │
Person            ├── Case-control study
Place             ├── Cohort study
Time              └── Cross-sectional study
 │                         │
Generates             Tests hypothesis
Hypothesis
                      +
                 EXPERIMENTAL
                      │
                 ├── RCT (gold standard)
                 ├── Field trials
                 └── Community trials

🔑 7. DESCRIPTIVE EPIDEMIOLOGY - Person, Place, Time

PERSON

  • Age, Sex, Race, Religion, Occupation, Marital status, Socioeconomic status

PLACE

  • Country, Region, Urban vs Rural, Local patterns

TIME

  • Secular trends - long-term changes over years/decades
  • Cyclic trends - periodic fluctuations (seasonal, 2-3 yearly cycles)
  • Point epidemic - all cases from single source at one time
  • Propagated epidemic - spread person to person

🔑 8. EPIDEMIOLOGY vs CLINICAL MEDICINE

FeatureEpidemiologyClinical Medicine
Unit of studyDefined populationIndividual patient/case
ConcernSick + Healthy bothSick only
ApproachGoes to communityPatient comes to doctor
MeasureRate (cases/population)Diagnosis + treatment
PurposePrevention + controlCure of individual
Key quote: "Clinician interested in cases; statistician in population; epidemiologist in the RATE (relationship between cases and population)"

🔑 9. BASIC MEASUREMENTS IN EPIDEMIOLOGY

RATES
  │
  ├── INCIDENCE RATE = New cases / Population at risk × K
  │                    (measures risk of disease)
  │
  ├── PREVALENCE RATE = All cases (new+old) / Total population × K
  │       │
  │       ├── Point prevalence (at one point in time)
  │       └── Period prevalence (over a period)
  │
  └── ATTACK RATE = Cases / Population exposed × 100
                    (used in outbreaks/epidemics)

RELATIONSHIP:
Prevalence ≈ Incidence × Duration of disease

🔑 10. EPIDEMIOLOGICAL METHODS (Quick Overview)

OBSERVATIONAL                    EXPERIMENTAL
      │                                │
 ┌────┴────┐                    ┌──────┴──────┐
DESC.   ANALYTIC               RCT        Field/
 │        │                  (gold        Community
Person  ┌──┴──┐              standard)     trials
Place   │     │
Time   Case  Cohort
       ctrl   │
         Retrospective  Prospective
         (exposure?)   (disease?)

🔑 11. KEY TERMS TO REMEMBER

TermDefinition
Incubation periodTime from exposure to onset of disease
Herd immunityResistance of a group to a disease when sufficient proportion immune
EndemicConstant presence of a disease in a given area
EpidemicOccurrence of disease in excess of normal expectancy
PandemicWorldwide epidemic
SporadicOccasional cases, no connection
Attack rateIncidence rate used in epidemic situations

⚡ RAPID RECALL - EXAM SHORTCUTS

DEFINITION = IEA = Occurrence + Distribution + Determinants + Application

AIMS = 3 (Describe + Identify + Provide data)

USES = 7 (Morris)
       ↓
   H-C-P-R-S-N-C

TYPES = Descriptive → Analytical → Experimental
              ↓              ↓              ↓
        Hypothesis     Test it       Prove it (RCT)
           generated

PERSON + PLACE + TIME = 3 variables of descriptive epi

INCIDENCE = new cases (risk measure)
PREVALENCE = all cases (burden measure)
P = I × D

Source: Park's Textbook of Preventive and Social Medicine

Communicable disease and related nhp in India

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have comprehensive data from Park's. Let me compile the complete rapid-revision sheet.

⚡ COMMUNICABLE DISEASES & NATIONAL HEALTH PROGRAMMES (NHP) IN INDIA

[PSM | 3rd MBBS | 30-Min Rapid Revision Sheet]

🔑 PART A: COMMUNICABLE DISEASE - CORE CONCEPTS

1. DEFINITION

A communicable disease is one that can be transmitted from an infected person/animal/environment to a susceptible host, directly or indirectly.

2. CHAIN OF INFECTION (Most Exam-Important Diagram) ⭐⭐

INFECTIOUS        RESERVOIR     PORT OF      MODE OF      PORT OF      SUSCEPTIBLE
  AGENT    →      OF             EXIT    →   TRANS-    →  ENTRY    →    HOST
(pathogen)       INFECTION                  MISSION
  │                 │              │            │            │             │
Bacteria         Human          Resp.        Direct       Resp.        No immunity
Virus            Animal         tract        Contact      tract        Malnutrition
Fungi            Environment    GIT          Indirect     GIT          Genetic
Parasite         Carrier        Skin         Airborne     Skin         Age/Sex
Rickettsia                      GUT          Vector       Mucosa
                                             Vehicle
                                             Fomite
Break ANY link = Disease prevented

3. MODES OF TRANSMISSION

TypeExamples
Direct contactSTDs, Rabies, Ringworm
Droplet/AirborneTB, Measles, COVID, Influenza
Faecal-oral (vehicle)Cholera, Typhoid, Polio, Hepatitis A
Vector-borneMalaria (Anopheles), Dengue (Aedes), Filaria (Culex)
Blood/parenteralHIV, Hepatitis B, C
Vertical (mother to child)HIV, Syphilis, Rubella, HBV

4. KEY DEFINITIONS

TermDefinition
Incubation periodTime from exposure to 1st symptom
Communicable periodPeriod when disease can be transmitted
CarrierInfected person who harbours pathogen without symptoms
Herd immunityGroup protection when sufficient proportion immune
ZoonosisDisease transmitted from animal to man
Notifiable diseaseMust be reported to health authorities by law

5. CONTROL OF COMMUNICABLE DISEASE

CONTROL MEASURES
      │
 ┌────┴──────────────────────┐
 │                           │
AT SOURCE                AT HOST              AT ENVIRONMENT
(Agent/Reservoir)             │                      │
 │                    Immunization           Sanitation
Isolation             Chemoprophylaxis       Safe water
Quarantine            Health education       Vector control
Disinfection          Nutrition              Waste disposal
Treatment             Screening

🔑 PART B: NATIONAL HEALTH PROGRAMMES - COMMUNICABLE DISEASES ⭐⭐

MASTER TABLE OF NHPs FOR COMMUNICABLE DISEASES

ProgrammeYear StartedTarget DiseaseKey Strategy
NTEP (earlier RNTCP/NTP)1962 (NTP), 1997 (RNTCP), renamed NTEP 2020TuberculosisDOTS
NVBDCP2003 (renamed from NAMP)Malaria, Dengue, Filaria, Kala-azar, JEVector control + drug treatment
NLEP1983LeprosyMDT
NACP1987HIV/AIDSNACO, ART, Prevention
NPCB1976Blindness (Trachoma etc.)Cataract surgery
National Immunization Programme1978 (EPI), 1985 (UIP)Vaccine-preventable diseasesUIP/Mission Indradhanush

🔑 1. NTEP - National TB Elimination Programme ⭐⭐

NTP (1962) → RNTCP (1997, DOTS) → End TB Strategy (2014) → NTEP (renamed 2020)
DOTS Strategy - 5 Components:
  1. Political will & administrative commitment
  2. Diagnosis by quality sputum smear microscopy
  3. Adequate supply of quality short-course chemotherapy
  4. Directly Observed Treatment (DOT)
  5. Systematic monitoring & accountability
STOP TB Strategy (2006) - Additional:
  • Address TB/HIV + MDR-TB
  • Strengthen health systems
  • Engage all care providers
  • Empower patients & communities
  • Enable/promote research
Objectives of RNTCP:
  • Cure rate ≥ 85% of infectious cases
  • Case detection ≥ 70% of estimated cases
Organization:
Central TB Division (CTD) - National
        ↓
State TB Cell (STO) - State
        ↓
District TB Centre (DTO) - District
        ↓
Peripheral Health Institutions (PHI)
End TB Target: Zero deaths, disease & suffering due to TB (by 2030)

🔑 2. NVBDCP - National Vector Borne Disease Control Programme ⭐⭐

Covers: Malaria, Dengue, Chikungunya, Lymphatic Filaria, Kala-azar, Japanese Encephalitis
Milestones of Malaria Programme:
YearEvent
1953NMCP launched (75 million cases pre-1953)
1958Renamed to NMEP (Eradication)
1965Cases reduced to 0.1 million ✓
1970sResurgence of malaria
1976Cases peaked at 6.46 million ✗
1999Renamed to NAMP
2002Renamed to NVBDCP
2016National Framework for Malaria Elimination launched
2017National Strategic Plan for Malaria Elimination 2017-2022
Key Interventions:
  • IRS (Indoor Residual Spraying) - DDT/Malathion
  • LLINs (Long-lasting insecticidal bed nets) - introduced 2009
  • RDT (Rapid Diagnostic Test) - introduced 2005
  • ACT (Artemisinin Combination Therapy) - introduced 2006 for Pf resistance
  • Larval control, biological control

🔑 3. NLEP - National Leprosy Eradication Programme ⭐

NLCP (1955) → NLEP (1983) → MDT introduced (1982 by WHO)
Goal: Elimination = <1 case per 10,000 population
India declared leprosy eliminated: 2005
MDT Regimens:
TypeDrugsDuration
Paucibacillary (PB)Dapsone + Rifampicin6 months
Multibacillary (MB)Dapsone + Rifampicin + Clofazimine12 months
Strategies: MDT, disability prevention, rehabilitation, IEC

🔑 4. NACP - National AIDS Control Programme ⭐⭐

1986: First HIV case in India
1987: NACP launched
NACO set up (under MoHFW)
Phases:
PhaseYearFocus
NACP-I1992-1999Slow down spread of HIV
NACP-II1999-2006Behaviour change, decentralization, NGO involvement
NACP-III2007-2012Halt and reverse epidemic
NACP-IV2012-2017Accelerating response
NSP2017-2024Ending AIDS
Key Milestones:
  • 2004: ART (Antiretroviral Treatment) initiated free
  • 2006: National Council on AIDS (PM as chairman)
  • State AIDS Control Societies established in all states
Aim of NACP:
  1. Prevent further HIV transmission
  2. Decrease morbidity & mortality
  3. Minimize socio-economic impact

🔑 5. NPCB - National Programme for Control of Blindness ⭐

  • Launched: 1976 (100% centrally sponsored)
  • Goal: Reduce blindness from 1.4% → 0.3%
  • Current prevalence (2015-19 survey): 0.36%
Signature Activities:
  • 66 lakh cataract operations/year
  • 9 lakh free spectacles to school children/year
  • 50,000 donated eyes for keratoplasty/year

🔑 6. UNIVERSAL IMMUNIZATION PROGRAMME (UIP) ⭐⭐

EPI (1978) → UIP (1985) → Mission Indradhanush (2014)
Vaccines under UIP:
VaccineDiseaseSchedule
BCGTBBirth
OPVPolio6, 10, 14 weeks + boosters
IPVPolio6 & 14 weeks
Hepatitis BHep BBirth, 6, 10, 14 weeks
DPTDiphtheria, Pertussis, Tetanus6, 10, 14 weeks
Hib (Pentavalent)H. influenzae b6, 10, 14 weeks
Measles/MRMeasles, Rubella9-12 months, 16-24 months
JEJapanese EncephalitisSelected districts
RotavirusRotavirus diarrhoeaSelected states
PCVPneumococcal6, 14 weeks, 9 months
TT/TdTetanus10, 16 years + pregnant women
Mission Indradhanush: Reach unvaccinated/partially vaccinated children - Target full immunization coverage

⚡ RAPID RECALL TABLE - NHPs at a Glance

DISEASE        PROGRAMME    YEAR     KEY STRATEGY
──────────────────────────────────────────────────
TB             NTEP         1962/97  DOTS + End TB
Malaria        NVBDCP       1953/02  ACT + LLINs + IRS
Leprosy        NLEP         1983     MDT (6/12 months)
HIV/AIDS       NACP/NACO    1987     ART + Prevention
Blindness      NPCB         1976     Cataract surgery
Filaria        NVBDCP       -        MDA (DEC + Albendazole)
Kala-azar      NVBDCP       -        Elimination by 2023
Dengue/Chik    NVBDCP       -        Vector control (Aedes)
Vaccines       UIP          1985     12 antigens covered

Source: Park's Textbook of Preventive and Social Medicine

Nhp for communicable diseases give them like answer to the question all imp points covered

Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Excellent - I now have all the data needed. Here is the complete exam-style structured answer:

National Health Programmes (NHP) for Communicable Diseases in India

[PSM - 3rd MBBS | Exam Answer Format | ~10-12 min per programme]

INTRODUCTION

National Health Programmes are centrally sponsored, goal-directed initiatives by the Government of India to reduce morbidity and mortality from major communicable diseases. Each programme operates through the national health care delivery system from central to peripheral level.

OVERVIEW FLOWCHART

COMMUNICABLE DISEASE NHPs IN INDIA
              │
    ┌─────────┼──────────┬──────────────┬──────────────┐
    │         │          │              │              │
  NTEP      NVBDCP     NLEP           NACP          UIP/NIS
(TB)      (Vector-   (Leprosy)     (HIV/AIDS)    (Immunization)
          borne)
            │
     ┌──────┼────────┬────────┐
   Malaria Dengue  Filaria  Kala-azar
           Chikungunya  JE

1. NATIONAL TB ELIMINATION PROGRAMME (NTEP) ⭐⭐

Evolution

NTP (1962) → RNTCP (1997, DOTS) → STOP TB (2006) → End TB (2014) → NTEP (renamed 2020)

Objectives

  1. Cure rate ≥ 85% of infectious cases through DOTS
  2. Case detection ≥ 70% of estimated cases by quality sputum microscopy

DOTS Strategy - 5 Components ⭐

#Component
1Political will & administrative commitment
2Diagnosis by quality-assured sputum smear microscopy
3Adequate supply of quality short-course chemotherapy drugs
4Directly Observed Treatment (DOT)
5Systematic monitoring & accountability

STOP TB Strategy (2006) - Additional Components

  • Pursuing quality DOTS expansion
  • Addressing TB/HIV & MDR-TB
  • Contributing to health system strengthening
  • Engaging all care providers
  • Empowering patients & communities
  • Enabling & promoting research

End TB Strategy (2014)

Vision: Zero deaths, disease and suffering due to TB (by 2030)

NTEP Organization Structure

Ministry of Health & Family Welfare
         ↓
Central TB Division (CTD) - National level
         ↓
State TB Cell (STO) - State level
         ↓
District TB Centre (DTO) - District level
         ↓
Peripheral Health Institutions (PHI)

Key Drugs

  • DOTS regimen: 2HRZE / 4HR (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol)
  • MDR-TB: Bedaquiline-based regimens (Group A, B, C classification)

2. NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME (NVBDCP) ⭐⭐

Diseases Covered

NVBDCP (2003)
    │
    ├── Malaria
    ├── Dengue & Chikungunya
    ├── Lymphatic Filariasis
    ├── Kala-azar (Visceral Leishmaniasis)
    └── Japanese Encephalitis (JE)

A. MALARIA - Programme Milestones

YearMilestone
Pre-195375 million cases, 0.8 million deaths
1953NMCP (National Malaria Control Programme) launched
1958Renamed NMEP (Eradication Programme)
1965Cases ↓ to 0.1 million
1970sResurgence - cases back to 6.46 million (1976)
1999Renamed NAMP
2002Renamed NVBDCP
2005RDT (Rapid Diagnostic Test) introduced
2006ACT (Artemisinin Combination Therapy) introduced for Pf resistance
2009LLINs (Long-Lasting Insecticidal Nets) introduced
2016National Framework for Malaria Elimination launched
2017National Strategic Plan for Malaria Elimination 2017-2022

Malaria Control Strategies

ANTI-MALARIA MEASURES
        │
   ┌────┴────┬──────────────┐
   │         │              │
PARASITE   VECTOR         HOST
  │            │              │
Diagnosis    IRS (DDT/     Chemoprophylaxis
RDT/Smear    Malathion)    Presumptive
ACT/CQ       Larvicides    treatment
treatment    LLINs         IEC
             Biological
             control

B. LYMPHATIC FILARIASIS ELIMINATION

  • Strategy: Annual MDA (Mass Drug Administration)
    • DEC alone (till 2007) → DEC + Albendazole (from 2007)
    • Given to all eligible persons except: pregnant women, children <2 years, seriously ill
  • Target: Elimination = microfilaria prevalence <1%
  • Started: 2004; All 250 endemic districts covered by 2007

C. KALA-AZAR (Visceral Leishmaniasis) Elimination

  • Target: <1 case per 10,000 population at block level
  • Drug of choice: Liposomal Amphotericin B (single dose)
  • Vector: Phlebotomus argentipes (sandfly) - indoor residual spraying

D. DENGUE & CHIKUNGUNYA

  • Vector: Aedes aegypti (breeds in clean stagnant water)
  • Control: Source reduction, larvicides, personal protection
  • No specific treatment / vaccine (dengue vaccine limited use)

3. NATIONAL LEPROSY ERADICATION PROGRAMME (NLEP) ⭐⭐

Timeline

NLCP (1955) → NLEP (1983) → WHO MDT introduced (1982) → Elimination achieved (2005)

Goal

Elimination = <1 case per 10,000 population at national level India achieved elimination at national level: 2005

MDT Regimens ⭐

TypeDrugsDuration
PB (Paucibacillary)Rifampicin + Dapsone6 months
MB (Multibacillary)Rifampicin + Dapsone + Clofazimine12 months
MDT = Monthly supervised + daily unsupervised doses

Classification of Leprosy

LEPROSY
   │
   ├── PB (1-5 skin patches, smear negative)
   │       → Tuberculoid (TT), Borderline Tuberculoid (BT)
   │
   └── MB (>5 skin patches, smear positive)
           → Borderline (BB), Borderline Lepromatous (BL), Lepromatous (LL)

Key Indicators

  • ANCDR: Annual New Case Detection Rate (per 1,00,000)
  • PR: Prevalence Rate (per 10,000)
  • Grade II disability rate among new cases
  • Child proportion among new cases (indicator of active transmission)

Strategies

  • Free MDT through government services
  • Disability prevention & rehabilitation
  • IEC for stigma reduction
  • Integration with general health services

4. NATIONAL AIDS CONTROL PROGRAMME (NACP) ⭐⭐

Timeline

1986: First HIV case in India
1987: NACP launched → NACO set up
1992: NACP-I → 1999: NACP-II → 2007: NACP-III → 2012: NACP-IV → 2017: NSP 2017-2024

Phases of NACP

PhaseYearFocus
NACP-I1992-1999Slow down HIV spread; surveillance
NACP-II1999-2006Behaviour change; decentralisation; NGO involvement
NACP-III2007-2012Halt & reverse epidemic; ART scale-up
NACP-IV2012-2017Accelerate response; concentrate on high-risk groups
NSP2017-2024Ending AIDS; 90-90-90 targets

Aims of NACP

  1. Prevent further HIV transmission
  2. Decrease morbidity & mortality associated with HIV
  3. Minimize socio-economic impact

NACO Structure

National AIDS Control Organization (NACO)
    - Under Ministry of Health & Family Welfare
         ↓
State AIDS Control Societies (SACS)
         ↓
District AIDS Prevention & Control Units (DAPCU)

Key Interventions

  • Free ART (Antiretroviral Treatment) - started 2004
  • ICTC (Integrated Counselling & Testing Centres)
  • PPTCT (Prevention of Parent to Child Transmission)
  • TI (Targeted Interventions) for high-risk groups (FSW, MSM, IDU, migrants)
  • Blood safety: National Blood Policy (2002)
  • Condom promotion, IEC

90-90-90 Targets (UNAIDS)

90% of people with HIV know their status
    → 90% of diagnosed on treatment
        → 90% of treated virally suppressed

5. UNIVERSAL IMMUNIZATION PROGRAMME (UIP) ⭐⭐

Evolution

EPI launched by WHO (1974) → EPI India (Jan 1978) → UIP launched (Nov 19, 1985)
Dedicated to memory of Smt. Indira Gandhi

National Immunization Schedule (Key vaccines) ⭐

VaccineDiseaseSchedule
BCGTBBirth
OPVPolioBirth, 6, 10, 14 wks; 16-18 months; 5 yrs
IPVPolio6 & 14 weeks
Hep BHepatitis BBirth, 6 wks, 14 wks
PentavalentDPT + HepB + Hib6, 10, 14 weeks
Measles/MRMeasles, Rubella9-12 months; 16-24 months
RotavirusDiarrhoea6, 10, 14 weeks (selected states)
PCVPneumonia6 wks, 14 wks, 9 months
JEJapanese Encephalitis9-12 months (endemic districts)
TTTetanus10 yrs, 16 yrs + Pregnant women

Mission Indradhanush (2014) ⭐

Reach all unvaccinated/partially vaccinated children under 2 years Target: Full immunization coverage → 90%

Cold Chain

State Vaccine Store → Regional/Divisional Store → District Store
    → CHC/PHC → Sub-Centre → Village (field worker/ANM)

SUMMARY TABLE - QUICK RECALL ⭐⭐

ProgrammeStartedTargetKey StrategyGoal
NTEP1962/1997/2020TBDOTSElimination by 2025
NVBDCP2003Malaria, Dengue, Filaria, KA, JEIRS, ACT, MDA, LLINsMalaria elimination 2027
NLEP1983LeprosyMDT (6/12 months)Elimination (achieved 2005)
NACP/NACO1987HIV/AIDSART, ICTC, TI90-90-90
UIP1985Vaccine-preventable12 antigens; cold chainUniversal coverage

Source: Park's Textbook of Preventive and Social Medicine
This is a shared conversation. Sign in to Orris to start your own chat.